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Summary We have produced human CEA transgenic mice which were found to express CEA mRNA in all
tissues. By immunoblot analysis using anti-CEA polyclonal antibody, we also detected CEA protein in all
tissues. However, the molecular size of CEA in the brain was different from that in other tissues, although the
mRNA size was same and no deletion nor rearrangement was detected at the DNA level. Immunohisto-
chemical analysis of the lung and the colon showed that the expression sites were the bronchial epithelial cells
of the lung and the columnar epithelial cells of the colon. Interestingly, the expression of CEA protein in the
transgenic mice was polarised to the luminal side of epithelial cells similar to the normal CEA expression in
human tissues. We also detected cell surface expression of human CEA on thymocytes and spleen cells and
CEA expression was greatly reduced by the phosphatidylinositol-specific phospholipase C (PI-PLC) treatment.
Carcinoembryonic antigen (CEA), a Mr.180,000 highly
glycosylated glycoprotein, was first described by Gold and
Freedman in 1965 as a colon tumour-specific antigen in
colonic carcinoma (Gold & Freedman, 1965a) and in foetal
colon (Gold & Freedman, 1965b). Later it was found that
CEA was also expressed in normal adult colon (Fritsche &
Mach, 1977; Egan et al., 1977), although the level of expres-
sion is lower than that in colon carcinoma (Boucher et al.,
1989). Although it lacks absolute tumour specificity because
of the presence of a member of immunologically closely
related antigens, such as nonspecific crossreacting antigen
(NCA) (von Kleist et al., 1972; Mach & Pusztaszeri, 1972),
CEA has been used as an important clinical tumour marker
(Tate, 1982). By molecular cloning of cDNA and genomic
sequences, primary structures of CEA and NCA were
deduced, and revealed that CEA (Oikawa et al., 1987a;
Zimmermann et al., 1987; Kamarck et al., 1987; Beauchemin
et al., 1987) and NCA (Oikawa et al., 1987b; Tawaragi et al.,
1988; Neumaier et al., 1988) have quite similar nucleotide
sequences and structures which belong to the immuno-
globulin superfamily (Oikawa et al., 1987c; Paxton et al.,
1987). The cell surface expression of CEA has been shown to
be that of a phosphatidylinositol glycan (PI-G) anchored
protein (Hefta et al., 1988; Takami et al., 1988; Hefta et al.,
1990), which was cleaved by phosphatidylinositol-specific
phospholipase C (PI-PLC) (Ikezawa et al., 1983) similar to
Thy-I molecule (Low & Kincade, 1985), the most primitive
molecule in the immunoglobulin superfamily. In addition,
recent reports have shown that the CEA molecule may be
involved in cell-to-cell adhesion (Benchimol et al., 1989;
Oikawa et al., 1989). From these findings, it has been sug-
gested that CEA might play some important roles in cell-cell
or cell-substrate recognition or may act as a receptor for
some ligands. However, these studies were carried out in vitro
using. transformed cells. To investigate the characteristics of
CEA expression in normal cells, we planned to produce
transgenic mice which express human CEA in various tissues.
In this paper, we report the characteristic pattern of expres-
sion of the human CEA gene in transgenic mice.
Materials and methods
DNA microinjection into mouse embryos
The DNA fragment, pdKCR-CEA, used for microinjection
was a HpaI-SalI digested fragment of the expression vector,
pdKCR-dhfr-CEA (Oikawa et al., 1989; O'Hare et al., 1981).
This fragment contains SV40 early promoter, P-globin splice
site and a 2.9 kb EcoRI fragment of full length CEA cDNA
but is lacking almost all of the dhfr gene. This fragment was
excised from low melting point agarose gel, purified by
phenol and chloroform extraction, further purified using
ELUTIP-d columns (Schleicher & Schuell GmbH: Dassel,
Germany), followed by ethanol precipitation and suspended
in TE (10 mM Tris pH 7.5 and 0.2 mM EDTA). DNA solu-
tion (5pgml-') was microinjected into the pronucleus of
fertilised eggs derived from the mating of C57BL/6 or BCF1
(C57BL/6 x Balb/c) females with C57BL/6 males. Eggs sur-
viving after microinjection were reimplanted into the oviducts
of pseudopregnant ddY females.
Analysis ofnucleic acids
Genomic DNA from various tissues was extracted as follows:
Each tissue was homogenised or minced in a solution con-
taining 50 mM Tris (pH 7.5), 100 mM EDTA, 100 mM NaCl
and 1% SDS. Proteinase K was added to a final concentra-
tion of 0.5%, and the solutions were incubated at 55°C
overnight. Digests were extracted with phenol and
chloroform three times and precipitated by ethanol. DNA
samples were digested by restriction enzymes, electrophoresed
through 0.8% agarose gels and transferred to Hybond-N
nylon membranes (Amersham).
Total RNA was extracted from various tissues of trans-
genic or non-transgenic mice following the methods described
by Chomczynski and Sacchi (Chomczynski & Sacchi, 1987).
About 20 gLg of each RNA preparation was electrophoresed
using 1.1 M formaldehyde in 1% agarose gels. The RNA was
transferred to Hybond-N nylon membranes. Detection of
injected DNA and mRNA with 32P-labelled (using Multi-
prime labelling system: Amersham) probe was carried out by
hybridisation for 18 h at 42°C in 5 x SSPE (1 x SSPE is
composed of 0.18 M NaCl, 10 mM sodium phosphate
(pH 7.7) and 1 mM EDTA), 5 x Denhart's solution (1 x Den-
hart's solution is composed of 0.02% bovine serum albumin,
0.02% Ficoll and 0.02% polyvinyl pyrollidone), 50% for-
mamide, 0.1% SDS, 50yg ml-' heat denatured salmon testis
DNA, and radioactive probe. Membranes were washed for
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15 min at 65°C in a solution containing 2 x SSC (1 x SSC is
composed of 0.15 M NaCl and 15 mM sodium citrate) with
0.1% SDS twice, followed by washing in 1 x SSC with 0.1%
SDS 30 min at 65°C, and a final wash for 15 min in 0.1 x SSC
with 0.1% SDS twice at room temperature. Autoradiography
of the membranes was then performed at - 70°C using Fuji
RX film. The hybridisation probe used was a PvuII digested
DNA fragment of the pCEA55-2 clone, CEA3 (Sato et al.,
1988). We analysed the density of the image of the
autoradiograms using the dual-wave length flying-spot scan-
ner CS-9000 (Shimadzu, Kyoto, Japan).
Immunoblotting analysis
Tissues were washed with phosphate buffered saline (PBS)
and homogenised. Extracts were sonicated and 10 IA of each
whole homogenate (about 10fig) was resolved by 7.5% SDS-
polyacrylamide gel electrophoresis (PAGE). The proteins
were electrophoretically transferred to nitrocellulose mem-
brane and visualised with rabbit anti-human CEA antibody
(DAKO, Denmark. Code Al15), which has been shown to be
reactive with both CEA and NCA (Oikawa et al., 1989).
Immunofluorescence and laserflow cytometry
Anti-human CEA polyclonal antibody was the same
antibody used for the immunoblotting analysis. Indirect
immunofluorescence analysis was performed using FITC-
conjugated anti-rabbit IgG goat antiserum (Organon Teknika
N.V.-Cappel Products, USA) as the second antibody. The
thymocytes and the spleen cells of the transgenic mice and
the control non-transgenic mice were reacted with the first
antibody for 1 h at 4°C. After three times washing, cells were
suspended in the medium containing the second antibody
and incubated for 1 h in 4°C. The stained cells were
resuspended in medium after three times washing and
analysed on a EPICS profile flow cytometer (Coulter Cor-
poration, Florida, USA). The thymocytes were treated with
PI-PLC (10 mU for 106 cells in 2001tl) for 1 h at 37°C. After
washing twice, the thymocytes were used for
immunofluorescent assay as described above.
Immunohistochemical analysis
The tissues were promptly fixed in periodate-lysine 4%
paraformaldehyde for 6 h, washed in PBS containing increas-
ing concentration of sucrose, frozen in OCT compound (Lab
Tek Products, Naperville, IL, USA), and sectioned 6tim
thick on a cryostat. The sections were placed on egg-albumin
coated slides and dried in air. Rabbit anti-human CEA
polyclonal antibody (DAKO, Denmark) was used as the first
antibody. Goat anti-rabbit F(ab')2 fragment of IgG labelled
with horse radish peroxidase (HRP) (donated by Prof.
Watanabe, Tokai University) was used as the second
antibody. Cryostat sections to be observed by light micro-
scopy were treated with 100% methanol containing 0.03%
hydrogen peroxidase to inactivate endogenous peroxidase.
The indirect HRP-labelled antibody method was used for
immunological reaction as previously described (Nagura et
al., 1986; Yamamoto et al., 1988). Briefly, the procedure
involves successive incubations with or without the first
antibodies in optimal dilutions for 12 h at 4°C, and the
second antibodies for 6 h at 4°C. Sections were then treated
with 0.25% diaminobenzidine (DAB) solution containing
0.01 M sodium azide and 0.01 M hydrogen peroxide, and
counter-stained with methyl green.
Results
Establishment oftransgenic mice lines expressing the CEA
genome
The HpaI-SalI DNA fragment ofpdKCR-CEA was microin-
jected into fertilised eggs. In total, 32 (B6 x BCF1) mice
and 3 B6 mice were born. The tail DNAs from these mice
were screened for the presence of human CEA DNA by
Southern blot analysis. Seven (B6 x BCF1) mice and two
B6 mice were shown to have human CEA DNA. All trans-
genic lines had complete human CEA cDNA (data not
shown). We then analysed the inserted human CEA cDNA in
various tissues including brain, thymus, lung, spleen, liver,
kidney and colon of one transgenic line B601 (B6 origin).
Southern hybridisation patterns following digestion with
EcoRI, PstI and PvuII were similar (Figure 1). We could not
detect any DNA deletions or rearrangement among the tis-
sues.
mRNA expressionfrom insertedhuman CEA cDNA
Total RNAs prepared from various tissues of the transgenic
mice and the control non-transgenic mice were subjected to
Northern blot analysis. When the human CEA cDNA probe
was used, 3.0 kb mRNA was detected in all tissues including
brain, thymus, lung, spleen, liver, kidney and colon of the
B601 line (Figure 2), but the level of CEA expression was
different among the tissues, possibly due to the function of
the SV40 promoter. In the normal control mice, we detected
3.0 kb mRNA only in the colon (Figure 2). This mRNA in
the colon of the normal mice may be the murine analogue of
CEA (Beauchemin et al., 1989). Other transgenic mice lines
had lower or no CEA mRNA expression in the tissues
examined (data not shown), although the Southern hybridisa-
tion pattern of tail DNA and copy number of inserted DNA
were not very different from those in the B601 line.
Characteristic expression ofhuman CEA protein in transgenic
mice
To study whether the expressed mRNA could be translated
to protein, we firstly carried out immunoblot analysis using
rabbit anti-human CEA polyclonal antibody (Figure 3). In
this analysis, we could clearly detect a protein of around
180 kD in all tissues (lane 1-5, 9) except the brain (lane 6).
We could not detect CEA protein in normal lung or colon
tissues (lane 7, 8). Interestingly, in the brain tissue, the
molecular size of protein was around 150 kD. These results
demonstrate that the inserted gene was transmitted to
mRNA thence to protein, although in the brain tissue a
different post-translational mechanism appears to operate.
The thymocytes ofthe B601 mice were examined by indirect
immunofluorescence with or without PI-PLC treatment. The
thymocytes of the transgenic mice showed definitive CEA
expression as demonstrated by anti-CEA polyclonal antibody
(Figure 4b). Such expression was greatly decreased by Pl-
PLC treatment (Figure 4c). The spleen cells of the B601 line
also showed human CEA expression, although some tech-
nical difficulties with cross-staining of the spleen B cells were
produced by the second antibody (Figure 4a).
To examine whether the expression sites of CEA protein in
the transgenic mice were the same as those of CEA in the
normal human colon and NCA in the normal lung, we
immunohistochemically analysed the lung and the colon of
the transgenic and normal mice. We used rabbit anti-human
CEA polyclonal antibody (which was the same antibody used
in the immunoblot analysis) as the first antibody and goat
anti-rabbit IgG antibody as the second antibody. In the
transgenic B601 mice, we could detect positive staining on
the luminal surface of the single layer of columnar epithelial
cells of the colon (Figure 5a). In the non-transgenic B6 mice,
weaker staining was detected (Figure Sb), suggesting cross-
reactivity of anti-human CEA polyclonal antibody to a
mouse intrinsic CEA-like molecule. In addition, in the lungs
of the tansgenic mice, the bronchial epithelial cells, especially
on the luminal side were much more strongly stained than
those of the normal mice with anti-human CEA polyclonal
antibody (Figure 5c,d). When the tissues were stained with
only the second antibody, essentially no staining was seen in
both the lung and the colon of the transgenic or the normal
mice and there were no differences (data not shown).712 T. HASEGAWA et al.
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Figure 1 Southern blot analysis of CEA in various tissues of CEA transgenic mice. DNA samples (10 gg) were digested with
EcoRI, PstI and PvuII, electrophoresed, blotted, and probed with 32P-labelled PvuII fragment of human CEA cDNA (Sato et al.,
1988) and filters were washed as described in 'Materials and methods' and autoradiographed. DNA was extracted from: lane 1,
brain; lane 2, thymus; lane 3, lung; lane 4, spleen; lane 5, liver; lane 6, kidney; lane 7, colon.
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Figure 2 Northern blot analysis of total RNA preparations from
various tissues of CEA transgenic and control mice. About 20 tLg
of total RNA were electrophoresed on a formaldehyde-agarose
gel, transferred to a nylon membrane and hybridised with the
32P-labelled PvuII fragment of CEA cDNA. After hybridisation,
the filters were washed as described in 'Materials and methods'
and autoradiographed. RNA was extracted from: lane 1, brain;
lane 2, thymus; lane 3, lung; lane 4, spleen; lane 5, liver; lane 6,
kidney; lane 7, colon. The relative intensities of each line of the
transgenic mice were as follows: lane 1, 13.8; lane 2, 97.7; lane 3,
107.3; lane 4, 97.5; lane 5, 1.0; lane 6, 120.9; lane 7, 52.9.
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Figure 3 Immunoblotting of CEA transgenic mice tissues with
rabbit anti-CEA antibody. Extracts (about 1O gsg) of lung (lane 1),
kidney (lane 2), liver (lane 3), spleen (lane 4), thymus (lane 5),
brain (lane 6) and colon (lane 9) were immunoblotted as de-
scribed in 'Materials and methods'. Lane 7 and lane 8 are the
normal lung and the normal colon, respectively.
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Figure 4 CEA expression on the surface of the thymus and the
spleen cells of the transgenic and the non-transgenic mice. Cells
were stained by indirect immunofluorescence method and 5,000
cells were analysed by FACS. a, Solid line, spleen cells of the
transgenic mice. Broken line, spleen cells of the normal mice. b,
Solid line, thymocytes of the transgenic mice. Broken line,
thymocytes of the normal mice. c, Solid line, thymocytes of the
transgenic mice without PI-PLC treatment. Broken line,
thymocytes of the transgenic mice with PI-PLC treatment (10 mU
for 106 cells in 200 gd).
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mice. d, Lung of the normal mice. Magnification x 400, respec-
tively.
Discussion
In this paper, we described the characteristic pattern of CEA
expression in transgenic mice. We confirmed human CEA
expression in various tissues of the transgenic mice by three
methods, including Northern hybridisation, immunoblotting
and immunohistochemistry. In the CEA transgenic mice, we
could detect 3.0 kb mRNA not only in the colon, but also in
the other tissues examined. Also by immunoblotting, we were
able to detect CEA protein in all tissues examined. We could
detect 3.0 kb mRNA but not CEA protein in the colon of
normal mice. This may be a crossreactivity to the mouse
analogue of CEA (Beauchemin et al., 1989). Interestingly the
molecular size of the protein was different in the brain. By
Southern hybridisation, we could not detect any differences
of restriction enzyme pattern in various tissues, and by
Northern hybridisation, the size of mRNA detected by
human CEA probe was the same in various tissues including
the brain. These results suggest that brain tissue showed the
different post-translational modification from other tissues.
In a immunohistochemical study, we could detect polarised
expression of CEA protein on the luminal side of epithelial
cells. This pattern of protein expression in the transgenic
mice was similar to that of normal human CEA. In normal
adult human colon, CEA appears mainly on the luminal
surface of the single layer of columnar epithelial cells lining
the upper parts of the crypts, and CEA is not present in the
basolateral membrane between adjacent cells, different from
foetal colon and malignant tissues. Our results are well cor-
related to the expression pattern of normal adult human
colon. In addition, in the normal lung, NCA is localised
mostly on the apical side of the epithelial cells of blonchioles
(Buchegger et al., 1984) and our findings of CEA expression
in transgenic mice are in agreement with that result. The
ectopic expressions of CEA on the thymocytes and spleen
cells were similar to the expression of murine Thy-1. Both
were cleaved by PI-PLC enzyme.
The function of CEA is not clearly understood. A recent
report has shown that the CEA molecule may have a role in
intercellular adhesion. (Benchimol et al., 1989). At the pre-
sent time our CEA transgenic mice remain healthy and we
are not able to detect any changes in the thymocyte or spleen
cell populations or any pathological changes in the lung and
the colon.
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